Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.73 |
| ▸ | HPGD | P15428 | 1/20 | 0.55 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.47 |
| ▸ | HSP90AA1 | P07900 | 3/20 | 0.45 |
| ▸ | HSP90AB1 | P08238 | 3/20 | 0.45 |
| ▸ | STK17A | Q9UEE5 | 1/20 | 0.44 |
| ▸ | SYK | P43405 | 6/20 | 0.41 |
| ▸ | FERMT2 | Q96AC1 | 1/20 | 0.39 |
| ▸ | CA12 | O43570 | 1/20 | 0.39 |
| ▸ | CA1 | P00915 | 1/20 | 0.39 |
| ▸ | CA2 | P00918 | 1/20 | 0.39 |
| ▸ | CA9 | Q16790 | 1/20 | 0.39 |
| ▸ | HRH1 | P35367 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8348328 | 0.93 | ALDH1A1 (0.70) | ALDH1A1HPGDHRH3HSP90AA1HSP90AB1 | |
| SCHEMBL20538899 | 0.91 | ALDH1A1 (0.67) | ALDH1A1HPGDHRH3HSP90AA1HSP90AB1 | |
| SCHEMBL9489416 | 0.91 | ALDH1A1 (0.67) | ALDH1A1HPGDHRH3HSP90AA1HSP90AB1 | |
| SCHEMBL26107919 | 0.91 | ALDH1A1 (0.67) | ALDH1A1HPGDHRH3HSP90AA1HSP90AB1 | |
| SCHEMBL1270863 | 0.86 | ALDH1A1 (0.71) | ALDH1A1HPGDSTK17ASYKFERMT2 | |
| Hydrochloric Acid SCHEMBL8179271 | 0.84 | ALDH1A1 (0.68) | ALDH1A1HPGDSTK17ASYKFERMT2 | |
| SCHEMBL18484921 | 0.83 | ALDH1A1 (0.55) | ALDH1A1HPGDHRH3HSP90AA1HSP90AB1 | |
| SCHEMBL6490227 | 0.77 | ALDH1A1 (0.65) | ALDH1A1HPGD | |
| SCHEMBL1268978 | 0.77 | ALDH1A1 (0.65) | ALDH1A1HPGD | |
| SCHEMBL5596514 | 0.77 | ALDH1A1 (0.42) | ALDH1A1HPGDHRH3HSP90AA1HSP90AB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 54 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170152443-A1 | LIQUID CRYSTAL ALIGNMENT AGENT, LIQUID CRYSTAL ALIGNMENT FILM, AND LIQUID CRYSTAL DISPLAY ELEMENT | CHI MEI CORPORATION (TW) | 2017-06-01 | — | — | US | disclosed |
| US-20170152443-A1 | LIQUID CRYSTAL ALIGNMENT AGENT, LIQUID CRYSTAL ALIGNMENT FILM, AND LIQUID CRYSTAL DISPLAY ELEMENT | CHI MEI CORPORATION (TW) | 2017-06-01 | — | — | US | disclosed |
| EP-0808316-B9 | VASOCONSTRICTIVE SUBSTITUTED 2,3-DIHYDRO-1,4-DIOXINOPYRIDINES | JANSSEN PHARMACEUTICA NV (BE) | 2004-12-01 | — | — | EP | disclosed |
| EP-0808316-B1 | VASOCONSTRICTIVE SUBSTITUTED 2,3-DIHYDRO-1,4-DIOXINOPYRIDINES | JANSSEN PHARMACEUTICA NV (BE) | 2004-03-31 | — | — | EP | disclosed |
| EP-0714396-B1 | VASOCONTRICTIVE DIHYDROBENZOPYRAN DERIVATIVES | JANSSEN PHARMACEUTICA NV (BE) | 2003-12-10 | — | — | EP | disclosed |
| CN-1066718-C | Vasoconstrictive substituted aryloxyalkyl diamines | JANSSEN PHARMACEUTICA NV (BE) | 2001-06-06 | — | — | CN | disclosed |
| US-6100268-A | MIGRAINES | JANSSEN PHARMACEUTICA, N.V. (BE) | 2000-08-08 | — | — | US | disclosed |
| CN-1052006-C | Dihydrobenzopyran derivatives as vasoconstrictors, preparation and use thereof | JANSSEN PHARMACEUTICA NV (NL) | 2000-05-03 | — | — | CN | disclosed |
| CN-1051085-C | Vasoconstrictive substituted dihydropyranopyridines | JANSSEN PHARMACEUTICA NV (BE) | 2000-04-05 | — | — | CN | disclosed |
| US-5990123-A | FOR TREATING MIGRAINE AND CEPHALIC PAIN, AND CONDITIONS RELATED TO VASODILATION; PHARMACUETICAL COMPOSITIONS AND METHODS OF SYNTHESIS VIA REDUCTIVE N-ALKYLATION | JANSSEN PHARMACEUTICA, N.V. (BE) | 1999-11-23 | — | — | US | disclosed |
| US-4154844-A | ANTIHISTAMINE, GASTRIC JUICE ANTISECRETORY AGENTS | SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) | 1979-05-15 | — | — | US | disclosed |
| US-4151288-A | ANTHISTAMINES | SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) | 1979-04-24 | — | — | US | disclosed |
| US-4137237-A | ANTIHISTAMINES | SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) | 1979-01-30 | — | — | US | disclosed |
| US-4137234-A | ANTIHISTAMINES | SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) | 1979-01-30 | — | — | US | disclosed |
| US-4070475-A | THIOALKYL-, AMINOALKYL-, AND OXYALKYL- SUBSTITUTED GUANIDINES | SMITH KLINE & FRENCH LABORATORIES LIMITED (EN) | 1978-01-24 | — | — | US | disclosed |
| US-4024271-A | INHIBITORS OF HISTAMINE ACTIVITY | SMITH KLINE & FRENCH LABORATORIES LIMITED (EN) | 1977-05-17 | — | — | US | disclosed |
| US-4022797-A | PHARMACEUTICALS | SMITH KLINE & FRENCH LABORATORIES LIMITED (EN) | 1977-05-10 | — | — | US | disclosed |
| US-4018931-A | INHIBITION OF H-2 HISTAMINE RECEPTORS | SMITH KLINE & FRENCH LABORATORIES LIMITED (EN) | 1977-04-19 | — | — | US | disclosed |
| US-3950333-A | HISTAMINE INHIBITORS, OXYALKYL, THIOALKYL, AMINOALKYL DERIVATIVES | SMITH KLINE & FRENCH LABORATORIES LIMITED (EN) | 1976-04-13 | — | — | US | disclosed |
| US-3950353-A | HISTAMINE INHIBITORS | SMITH KLINE & FRENCH LABORATORIES LIMITED (EN) | 1976-04-13 | — | — | US | disclosed |